Patents by Inventor Andrew R. Ferguson

Andrew R. Ferguson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating cancer with anti-TIM-3 antibodies
    Patent number: 11926665
    Abstract: The present disclosure provides methods of administering certain TIM-3 binding agents to patients having cancer. Dosage regimens for compositions comprising a TIM-3 binding agent are also explicitly provided.
    Type: Grant
    Filed: January 9, 2018
    Date of Patent: March 12, 2024
    Assignee: TESARO, INC.
    Inventors: Dmitri Bobilev, Andrew R. Ferguson, Kristen Anne McEachern, Jing Wang
  • COMBINATION THERAPIES FOR TREATING CANCER
    Publication number: 20200289493
    Abstract: The present invention provides methods of treatment for recurrent cancer(s) through combination therapy with an agent that inhibits programmed death-1 protein (PD-1) signaling and an agent that inhibits poly [ADP-ribose] polymerase (PARP) signaling.
    Type: Application
    Filed: May 9, 2018
    Publication date: September 17, 2020
    Applicants: TESARO, Inc., MERCK SHARP & DOHME B.V.
    Inventors: Dmitri Bobilev, Bruce Dezube, Peng Sun, Andrew R. Ferguson
  • METHODS OF TREATING CANCER WITH ANTI-TIM-3 ANTIBODIES
    Publication number: 20190322746
    Abstract: The present disclosure provides methods of administering certain TIM-3 binding agents to patients having cancer. Dosage regimens for compositions comprising a TIM-3 binding agent are also explicitly provided.
    Type: Application
    Filed: January 9, 2018
    Publication date: October 24, 2019
    Inventors: Dmitri Bobilev, Andrew R. Ferguson, Kristen Anne McEachern, Jing Wang